James Hoekstra to Adrenergic beta-Antagonists
This is a "connection" page, showing publications James Hoekstra has written about Adrenergic beta-Antagonists.
Connection Strength
0.314
-
Allen LaPointe NM, Chen AY, Roe MT, Cohen DJ, Diercks DB, Hoekstra JW, Fesmire FM, Gibler WB, Ohman EM, Peterson ED. Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome. Am J Cardiol. 2009 Nov 15; 104(10):1324-9.
Score: 0.085
-
Fermann GJ, Raja AS, Peterson ED, Roe MT, Hoekstra JW, Milford-Beland S, Diercks DB, Pollack CV, Peacock WF, Summers R, Ohman EM, Gibler WB. Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care. Clin Cardiol. 2009 Sep; 32(9):519-25.
Score: 0.085
-
Miller CD, Roe MT, Mulgund J, Hoekstra JW, Santos R, Pollack CV, Ohman EM, Gibler WB, Peterson ED. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med. 2007 Aug; 120(8):685-92.
Score: 0.073
-
Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J. 2007 May; 28(9):1079-84.
Score: 0.072